Current Aspects of Radiopharmaceutical Chemistry

Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging techniques which are widely used in nuclear medicine for the diagnosis and treatment follow-up of many major diseases. They use biomolecules as probes, which are labeled with radio...

Full description

Saved in:
Bibliographic Details
Main Author: Peter Brust (Ed.) (auth)
Format: Book Chapter
Published: MDPI - Multidisciplinary Digital Publishing Institute 2018
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02535naaaa2200361uu 4500
001 doab_20_500_12854_44407
005 20210211
020 |a books978-3-03897-163-4 
020 |a 9783038971627 
020 |a 9783038971634 
024 7 |a 10.3390/books978-3-03897-163-4  |c doi 
041 0 |a English 
042 |a dc 
100 1 |a Peter Brust (Ed.)  |4 auth 
245 1 0 |a Current Aspects of Radiopharmaceutical Chemistry 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2018 
300 |a 1 electronic resource (216 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging techniques which are widely used in nuclear medicine for the diagnosis and treatment follow-up of many major diseases. They use biomolecules as probes, which are labeled with radionuclides of short half-lives, synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. Their design and development require a rather interdisciplinary process involving many different disciplines of natural and health sciences. In addition to their diagnostic and therapeutic purposes in the field of nuclear medicine, radiopharmaceuticals provide powerful tools for in vivo pharmacology during the process of pre-clinical drug development to identify new drug targets, investigate the pathophysiology of diseases, discover potential drug candidates, and evaluate the pharmacokinetics and pharmacodynamics of drugs in vivo. Furthermore, they allow molecular imaging studies in various small-animal models of disease, including genetically engineered animals. The current collection of articles provides unique examples covering all major aspects in the field. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
653 |a Neuroimaging 
653 |a Structure-based radiotracer design 
653 |a Radiotracer metabolism 
653 |a Radiolabelling 
653 |a Fluorine-18 chemistry 
653 |a Radionuclide generators 
653 |a Target validation 
653 |a Ligand-based radiotracer design 
653 |a Tumor imaging 
653 |a Carbon-11 chemistry 
856 4 0 |a www.oapen.org  |u http://www.mdpi.com/books/pdfview/book/739  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/44407  |7 0  |z DOAB: description of the publication